MarketCap
Facebook
X
Telegram
Meridian Bioscience EV - Enterprise Value | VIVO
Annual EV - Enterprise Value Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.3 B | 833 M | 747 M | 488 M | 741 M | 586 M | 719 M | 719 M | 546 M | 864 M | 637 M | 568 M | -37.9 M | -54 M | -49.3 M | -49.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.3 B | -54 M | 535 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Neuronetics
STIM
|
168 M | $ 2.93 | 1.74 % | $ 193 M |  USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 603.02 | 0.02 % | $ 227 B | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 128.06 | 2.68 % | $ 7.66 B | USA |
 |
Senseonics Holdings
SENS
|
376 M | $ 9.33 | 5.97 % | $ 389 M | USA |
 |
Sotera Health Company
SHC
|
7.07 B | $ 18.59 | 0.05 % | $ 5.28 B | USA |
 |
VolitionRx Limited
VNRX
|
66.5 M | $ 0.33 | 2.52 % | $ 41.5 M |  Singapore |
 |
Waters Corporation
WAT
|
21.6 B | $ 402.91 | 0.33 % | $ 24 B | USA |
 |
Exagen
XGN
|
78.4 M | $ 7.3 | 0.53 % | $ 157 M | USA |
 |
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Trinity Biotech plc
TRIB
|
327 M | $ 9.06 | 0.64 % | $ 3.25 B |  Irlanda |
 |
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Psychemedics Corporation
PMD
|
1.77 M | - | -1.84 % | $ 15.3 M | USA |
 |
Quotient Limited
QTNT
|
273 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 235.5 | 0.06 % | $ 26.1 B | USA |
 |
Syneos Health
SYNH
|
4.59 B | - | - | $ 4.46 B | USA |
 |
T2 Biosystems
TTOO
|
54.9 M | - | -39.35 % | $ 313 K | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K |  Israel |
 |
Brainsway Ltd.
BWAY
|
231 M | $ 14.16 | 0.07 % | $ 481 M | Israel |
 |
Renalytix AI plc
RNLX
|
33.9 M | - | 5.66 % | $ 22.7 M |  Britain |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Quidel Corporation
QDEL
|
460 M | $ 13.38 | 0.29 % | $ 564 M | USA |
 |
Precipio
PRPO
|
42.5 M | $ 27.25 | 0.11 % | $ 43.7 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | Britain |
 |
Anixa Biosciences
ANIX
|
990 K | $ 2.9 | 0.66 % | $ 94.1 K | USA |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
|
Biodesix
BDSX
|
184 M | $ 26.63 | 1.72 % | $ 201 M | USA |
 |
Biomerica
BMRA
|
8.91 M | $ 2.34 | 1.3 % | $ 6.82 M | USA |
 |
BioNano Genomics
BNGO
|
34.1 M | $ 1.2 | 1.25 % | $ 6.53 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-193 M | $ 10.71 | 11.22 % | $ 113 M |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Agilent Technologies
A
|
35.7 B | $ 146.85 | 0.59 % | $ 41.7 B | USA |
|
Centogene N.V.
CNTG
|
-8.4 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
654 M | - | 0.12 % | $ 80.1 M | China |
 |
Bioventus
BVS
|
1.01 B | $ 13.83 | 0.42 % | $ 921 M | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 50.31 | 2.05 % | $ 2.68 B | USA |
 |
Celcuity
CELC
|
5.57 B | $ 93.02 | 0.75 % | $ 4.35 B | USA |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 1.12 | 2.55 % | $ 1.49 M | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 280.76 | 0.54 % | $ 13.9 B | USA |
 |
Castle Biosciences
CSTL
|
463 M | $ 32.76 | 1.03 % | $ 950 M | USA |
 |
Danaher Corporation
DHR
|
145 B | $ 205.23 | 0.53 % | $ 146 B | USA |
 |
DarioHealth Corp.
DRIO
|
11 M | $ 7.03 | 3.72 % | $ 28 M | Israel |
 |
DexCom
DXCM
|
28.2 B | $ 84.53 | 0.02 % | $ 33 B | USA |
 |
Fulgent Genetics
FLGT
|
583 M | $ 20.2 | 2.38 % | $ 622 M | USA |